Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Liminal BioSciences
Biotech
Liminal takes buyout from top shareholder at peach of a price
Liminal BioSciences' buyout comes more than six months after the company announced it'd be conserving cash to focus on core assets.
Max Bayer
Jul 12, 2023 11:00am
Annexon, Liminal shrink pipelines to focus on possible homeruns
Jan 9, 2023 11:37am
Liminal stops plan to advance fibrosis drug after seeing PK data
Jun 1, 2021 8:50am
